Johnson & Johnson Medical recently announced it purchased German 3D-printed spinal implants specialist Emerging Implant Technologies (EIT) for an undisclosed amount.

The EIT portfolio comprises titanium interbody implants for spinal fusion surgery. Remember, in January, the company was granted FDA multilevel approval for its 3D printed cervical cage. Applications of this approval concern multiple contiguous cervical levels (C2 to T1).

EIT Cellular Titanium® is a 3D printed porous titanium structure that has been designed by taking into account scientific insights on ideal pore shape and size. The aim is to optimize cell proliferation and bone ingrowth.

These technologies will now be available via the Johnson & Johnson Medical Devices Companies’ commercial infrastructure.

How does J&J orthopaedics unit DePuy Synthes benefit from this acquisition?

The EIT technology will complete DePuy Synthes’ work on the interbody implant segment for minimally invasive as well as open spinal surgery.

Indeed, the unit will take advantage of the acquisition to strengthen interbody implants line. The latter includes interbody devices and titanium integrated PEEK technology.

DePuy Synthes company group chairman Aldo Denti said: “Our goal is to offer a complete portfolio of interbody solutions that provides surgeons with even more options for the treatment of their patients.

We are excited to welcome the skilled team at EIT, and together, we aspire to bring to market technologies that allow surgeons to perform spinal fusion procedures reliably and with consistent outcomes.

The next step

Further researches will be carried out to develop solutions for spinal disease states that might drastically change the work of surgeons and the life of patients who suffer from degenerative disc disease, deformity and complex cervical.

Last but not least, DePuy Synthes will launch a range of technologies, such as interbody implants, minimally invasive spine (MIS), biomaterials and enabling technologies.

For further information about 3D Printing, follow us on our social networks and subscribe to our newsletter!

Would you like to be featured in the next issue of our digital magazine? Send us an email at